The global neurovascular devices market size in 2026 is witnessing strong growth as healthcare systems increasingly focus on the diagnosis and treatment of neurovascular conditions. Neurovascular devices include stenting systems, embolization devices, neurothrombectomy devices, and support devices used in the treatment of conditions such as cerebral aneurysms and ischemic stroke. According to Fortune Business Insights, the global neurovascular devices market size was valued at USD 4.08 billion in 2025 and is projected to grow from USD 4.46 billion in 2026 to USD 9.82 billion by 2034, exhibiting a CAGR of 10.40% during the forecast period. North America dominated the global market with a 43.60% share in 2025.
Neurovascular devices are specialized medical products designed for minimally invasive procedures involving blood vessels in the brain and surrounding areas. These devices support the management of neurovascular disorders, including cerebral aneurysms and ischemic stroke. Stenting systems, embolization devices, and neurothrombectomy devices represent important product categories within the market. The increasing prevalence of neurovascular conditions, particularly among the geriatric population, is contributing to demand for these products. Growing healthcare expenditure, improved awareness of treatment options, reimbursement policies, and advances in medical technology are also supporting the adoption of neurovascular interventions.
The rising incidence of neurovascular conditions is a major factor supporting market growth. The Fortune Business Insights report highlights the increasing prevalence of stroke, cerebral aneurysms, and other neurological conditions globally. The burden of these diseases is particularly significant among the aging population. Increasing healthcare expenditure and awareness of effective treatment options are encouraging more patients to undergo neurovascular procedures.
Government initiatives and healthcare organizations are also focusing on improving awareness, diagnosis, and management of neurological disorders. Such initiatives, combined with improving healthcare infrastructure in emerging countries, are expected to support the adoption of neurovascular devices.
Technological advancement is another important market driver. Market participants are investing in research and development to introduce advanced embolic coils, aspiration catheters, revascularization devices, and other products. Clinical studies are also being conducted to establish the efficiency of pipeline technologies and address unmet needs in neurovascular intervention.
However, limitations associated with diagnosis and treatment may restrict market expansion. Delayed diagnosis and misdiagnosis of brain aneurysms remain challenges, particularly where brain imaging facilities, specialized expertise, healthcare infrastructure, and established treatment guidelines are limited. These factors can affect timely treatment and consequently limit the adoption of neurovascular devices in certain markets.